Troutman Pepper advised Larimar Therapeutics, Inc. on the deal. Larimar Therapeutics, Inc. (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases,...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised Innervace on the deal. Innervace, a regenerative medicine company developing the first implantable biofabricated neural pathway to restore brain circuitry, announced its $40...
You must be a Standard 1 Year member to access this content.
Venable represented Avalon Acquisition Inc. on the deal. Avalon Acquisition Inc. (NASDAQ: AVAC), a publicly traded special-purpose acquisition company, signed the definitive merger agreement with the...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins advised Stronghold Digital Mining, Inc. on the deal. Stronghold Digital Mining, Inc. (the “Company”) announced a private placement transaction with each an institutional investor...
You must be a Standard 1 Year member to access this content.
Fenwick represented Aceragen on the deal, Morgan Lewis advised Idera Pharmaceuticals. Aceragen, a privately-held biotechnology company addressing rare, orphan pulmonary and rheumatic diseases for which there...
You must be a Standard 1 Year member to access this content.
Fenwick represented Scribe Therapeutics on the deal. Scribe Therapeutics, a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, announced its strategic collaboration and...
You must be a Standard 1 Year member to access this content.
Fenwick represented Malwarebytes on the deal while Paul Hastings LLP represented Vector Capital. Malwarebytes, a company specializing in real-time cyberprotection, announced its strategic $100 million minority investment...
You must be a Standard 1 Year member to access this content.
Fenwick represented InnerPlant on the deal. InnerPlant, a plant physiology company that gathers loads of data to make farming more efficient and sustainable, announced its $16 million...
You must be a Standard 1 Year member to access this content.
Fenwick represented Third Harmonic Bio, Inc. on the deal. Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT...
You must be a Standard 1 Year member to access this content.
Sidley represented Brand Velocity Group (BVG) on the deal. Norton Rose Fulbright represented SCORE Sports. Brand Velocity Group (BVG) announced its acquisition of SCORE® Sports (SCORE), a...
You must be a Standard 1 Year member to access this content.
Sidley and Houthoff represented IDEX Corporation on the deal. De Brauw advised Rivean Capital. IDEX Corporation announced its definitive agreement to acquire micro-precision technology manufacturing company Muon...
You must be a Standard 1 Year member to access this content.
Sidley represented Fifth Wall on the deal. Fifth Wall acted as lead investor in the Series C funding round of Ascend Elements, a battery recycling startup...
You must be a Standard 1 Year member to access this content.
